David Tuller
Trial By Error: The Surprising New BMJ Best Practice Guide
By David Tuller
By Steven Lubet, JD, and David Tuller, DrPH Update: Nov 13th We wrote this post based on a version of the guide that appeared recently and had been updated on July 31, 2017. That version lists Peter White as among three peer-reviewers. As commenters pointed out soon after the post ...
Trial By Error: Current NICE Guidance Stands, For Now
By David Tuller
By David Tuller, DrPH Last week I sent an e-mail with some questions to Sir Andrew Dillon, the chief executive of the National Institute for Health and Care Excellence (NICE). In particular, the questions involved the status of the ten-year-old guidance for CFS/ME, CG53, and of references to the illness ...
Trial By Error: Another Letter to NICE’s Sir Andrew Dillon
By David Tuller
By David Tuller, DrPH First, for those who might have missed it, here's a conversation from This Week in Virology (TWiV), posted a few days ago. Dr. Racaniello and I discuss the CDC, NICE, Esther Crawley's ethically challenged behavior, the CMRC, and other stuff. Second, earlier today, I sent the ...
Trial By Error: NIH Grants $2.1 Million to UK Biobank!
By David Tuller
By David Tuller, DrPH The National Institutes of Health is making a $2.1 million grant to the UK ME/CFS Biobank--a huge endorsement of this important project run by CureME and housed at the London School of Hygiene and Tropical Medicine. Here's what the ME Association wrote on its website: The ...
Trial By Error: NICE Rejects Current Guidance, Plans “Full Update”
By David Tuller
By David Tuller, DrPH Let's give credit where it's due. Apparently someone with decision-making authority at the National Institute for Health and Care Excellence (NICE) has a grasp on reality and is willing to challenge the claims of the biopsychosocial ideological brigades. That's the only logical explanation for last Wednesday's ...